playslotsonlinefree| Shengnuo Pharmaceuticals-B(02257): Dai Xiaochang resigns as Chief Strategy Officer

Shengnuo Pharmaceuticals-B(02257) issued an announcementplayslotsonlinefree, Dai Xiaochang resigned as the group's chief strategy officer due to personal reasonsplayslotsonlinefree, effective from May 17, 2024. Dr. Dai will continue to serve as executive director and agreed to serve as senior consultant for the group's drug development and commercialization.

Tags:

Prev: fivecarddraw| Hutchison Pharmaceutical (00013.HK): Du Zhiqiang resigns as chairman and takes over
Next: tangierscasinonodepositbonus| Sinus Electric: New energy business revenue is expected to increase significantly in 2024